ABEONA THERAPEUTICS INC. (ABEO) ROI
- 2026-06-30: ROI -43.96%.
- 2026-03-31: ROI 40.57%.
- 2025-12-31: ROI 39.71%.
- 2025-09-30: ROI 43.12%.
Complete source-backed roi history.
- Available history
- 2024-06-30 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -43.96% |
| 2026-03-31 | 40.57% |
| 2025-12-31 | 39.71% |
| 2025-09-30 | 43.12% |
| 2025-06-30 | 31.26% |
| 2025-03-31 | -72.81% |
| 2024-12-31 | -101.17% |
| 2024-09-30 | -110.26% |
| 2024-06-30 | -57.42% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | 39.71% |
| 2024-12-31 | -101.17% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |